Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.

A machine learning model can predict scarring in lichen planopilaris using factors like vitamin D levels and diagnostic delay.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

The report suggests a possible link between hair loss and hidden scalp tumors but states more evidence is needed to confirm this.

Alopecia greatly lowers the quality of life for South African Black women, especially affecting their self-image and social interactions.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Some breast cancer chemotherapy can cause permanent hair loss.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Herbal medications might be safer and more effective for hair loss than synthetic treatments.

Homeopathy and exosome therapy improved hair growth and health in a man with advanced hair loss.